Pomalidomide in multiple myeloma: No hints of added benefit
Pomalidomide (trade name: Imnovid) has been approved since 2013 for the treatment of multiple myeloma that has returned and is difficult to treat. The drug is an option for adults who have received two or more prior treatment ...
Jan 12, 2016
0
1